Medigen Vaccine Biologics Corp 結果共2筆

Vice Presidential candidate Hsiao Bi-khim of the Democratic Progressive Party (DPP) vows to review and reflect on corruption allegations within the DPP government. This comes after her opponent, Kuomintang’s (KMT) Jaw Shaw-kong, accused the DPP of corruption during a policy presentation. Jaw raised concerns about the DPP obstructing Terry Gou’s acquisition of Pfizer-BioNTech vaccines and questioned the increase in the market value of Medigen Vaccine Biologics Corp. He advocated for the reinstatement of the Special Investigation Division to tackle corruption. Hsiao acknowledges mistakes within the party and emphasizes the need for self-review. She highlights the DPP’s commitment to reform and progressive policies, citing examples of marriage equality and energy transformation. Hsiao compares the government to a team in an international competition, emphasizing the importance of guidance and support for a unified nation.

The Taiwan FactCheck Center has clarified that MVC’s quadrivalent influenza vaccine is produced by the reputable South Korean pharmaceutical firm GC Biopharma, which has WHO qualification and is marketed in multiple countries. Additionally, the FactCheck Center noted that MVC’s method of vaccine production is not unprecedented, as other domestic manufacturers have also imported foreign vaccine stock solutions for local assembly.